Insulin resistance: an independent risk factor for cardiovascular disease?
- PMID: 11220285
- DOI: 10.1046/j.1463-1326.1999.0010s1023.x
Insulin resistance: an independent risk factor for cardiovascular disease?
Abstract
Population-based studies have shown that patients with type 2 diabetes have a higher cardiovascular morbidity and mortality and an increased all-cause mortality compared with non-diabetic subjects. In non-diabetic subjects, hyperinsulinaemia not only has been associated with an increased cardiovascular risk, but is also related with a number of other cardiovascular risk factors--hyperglycaemia, hypertension, dyslipidaemia, and a central body fat distribution--that constitute the insulin resistance syndrome and are also characteristic of type 2 diabetes. After 23 years of follow-up in the Paris Prospective Study, both fasting and 2-h insulin concentrations were related with all-cause mortality in a U-shaped fashion, with low and high concentrations being associated with an increased risk, independently of other risk factors; in contrast, while high insulin levels carried an increased risk for cardiovascular and coronary heart disease mortality, this was not independent of other risk factors.
Similar articles
-
Hyperinsulinemia and cardiovascular risk.Heart Lung. 1994 Mar-Apr;23(2):118-22; 123-4. Heart Lung. 1994. PMID: 8206768 Review.
-
Clustering of cardiovascular risk factors in type 2 diabetes mellitus: prognostic significance and tracking.Diabetes Obes Metab. 2001 Feb;3(1):17-23. doi: 10.1046/j.1463-1326.2001.00093.x. Diabetes Obes Metab. 2001. PMID: 11213595
-
[Pathogenic role of hyperinsulinism in macroangiopathy. Epidemiological data].Presse Med. 1992 Sep 9;21(28):1307-11. Presse Med. 1992. PMID: 1438099 Review. French.
-
[Epidemiology of cardio-vascular complications of diabetes].Diabetes Metab. 1999 Jun;25 Suppl 3:12-20. Diabetes Metab. 1999. PMID: 10421988 Review. French.
-
The relation between insulin resistance and cardiovascular complications of the insulin resistance syndrome.Diabetes Obes Metab. 1999 May;1 Suppl 1:S8-16. doi: 10.1046/j.1463-1326.1999.0010s1008.x. Diabetes Obes Metab. 1999. PMID: 11220289 Review.
Cited by
-
EVALUATION OF THE RELATIONSHIP BETWEEN MEDICAL NUTRITION TREATMENT, PENTRAXIN-3, HSCRP AND BODY COMPOSITION ANALYSIS IN TYPE 2 DIABETIC PATIENTS.Acta Endocrinol (Buchar). 2023 Apr-Jun;19(2):169-177. doi: 10.4183/aeb.2023.169. Epub 2023 Oct 27. Acta Endocrinol (Buchar). 2023. PMID: 37908879 Free PMC article.
-
Predictive Effect of Alternative Insulin Resistance Indexes on Adverse Cardiovascular Events in Patients with Metabolic Syndrome with Heart Failure.Diabetes Metab Syndr Obes. 2024 Jun 10;17:2347-2356. doi: 10.2147/DMSO.S457598. eCollection 2024. Diabetes Metab Syndr Obes. 2024. PMID: 38881693 Free PMC article.
-
Impact of postprandial glycaemia on health and prevention of disease.Obes Rev. 2012 Oct;13(10):923-84. doi: 10.1111/j.1467-789X.2012.01011.x. Epub 2012 Jul 11. Obes Rev. 2012. PMID: 22780564 Free PMC article. Review.
-
Prevalence of diabetes and other cardiovascular risk factors in an Iranian population with acute coronary syndrome.Cardiovasc Diabetol. 2006 Jul 17;5:15. doi: 10.1186/1475-2840-5-15. Cardiovasc Diabetol. 2006. PMID: 16842631 Free PMC article.
-
Dyslipidemia of the metabolic syndrome.Curr Cardiol Rep. 2002 Nov;4(6):494-500. doi: 10.1007/s11886-002-0113-6. Curr Cardiol Rep. 2002. PMID: 12379172 Review.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources